reference/16635469

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16635469

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase II\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1397
issn	0009-7322 1524-4539
issueIdentifier	11
pageRange	1390-1397
publicationName	Circulation
startingPage	1390
bibliographicCitation	Mehta SR, Steg PG, Granger CB, Bassand JP, Faxon DP, Weitz JI, Afzal R, Rush B, Peters RJ, Natarajan MK, Velianou JL, Goodhart DM, Labinaz M, Tanguay JF, Fox KA, Yusuf S; ASPIRE Investigators. Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial. Circulation. 2005 Mar 22;111(11):1390–7. doi: 10.1161/01.cir.0000158485.70761.67. PMID: 15781750.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4aa27e0f09c742cc8fa26323353dc0c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21eb25f942bf77cdf7bfd2dd69b0dade http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9139aaba2053b36d3cd4871ce247f31e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb793fbc363ef0f33084762874038e64 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4776-5601 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0faaafed2005649b4bd3a64312e21e96 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dacc5b7b431ed648bf7ed5359b1f5e2b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65c20e73ef14b74e1d752caf37534b58 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21fef99a279e58fa84dbe4a869b0e60c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f0e6b82a20ae9a7807a33c4fe125c70 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_287dbf1587526b6b893cf140b086a6bd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_399eb01e76db6047817bd5251446bb74 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24dc83a8b9913431ef15eb2a58192b9e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3be1a9b673d4f4d5dd69cdab27ff94da http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c43848a698f5fbe84e56171fdf0a48e8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a59f85943559e5a09c1e3eec644aceb7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24604e28502fb3c4f9789c7fdf3a41ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6896-2941
date	2005-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1161/01.cir.0000158485.70761.67 https://pubmed.ncbi.nlm.nih.gov/15781750
isPartOf	https://portal.issn.org/resource/ISSN/1524-4539 https://portal.issn.org/resource/ISSN/0009-7322 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2979
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial
discusses	http://id.nlm.nih.gov/mesh/M0001380 http://id.nlm.nih.gov/mesh/M0010187 http://id.nlm.nih.gov/mesh/M0403648 http://id.nlm.nih.gov/mesh/M0017249 http://id.nlm.nih.gov/mesh/M0587609
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006493Q000627 http://id.nlm.nih.gov/mesh/D015906 http://id.nlm.nih.gov/mesh/D011134Q000627 http://id.nlm.nih.gov/mesh/D000925Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D009203Q000453 http://id.nlm.nih.gov/mesh/D000077425 http://id.nlm.nih.gov/mesh/D015607 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006493Q000009 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D011134Q000009 http://id.nlm.nih.gov/mesh/D016037 http://id.nlm.nih.gov/mesh/D017052 http://id.nlm.nih.gov/mesh/D005240 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D006470Q000209 http://id.nlm.nih.gov/mesh/D010865 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000925Q000009 http://id.nlm.nih.gov/mesh/D004630 http://id.nlm.nih.gov/mesh/D065427 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009204Q000706
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49852403 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3667f6a0c97490758d7dc9659d01ea34 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282448 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID636380 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9b21d1a174c364b6f99c6662d34d6034 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49852292 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10516

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248153327

Total number of triples: 77.